Literature DB >> 16151041

CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion.

Yi-Qiang Chen1, Huan-Zhong Shi, Xue-Jun Qin, Wu-Ning Mo, Xiang-Dong Liang, Ze-Xin Huang, Hai-Bo Yang, Cong Wu.   

Abstract

BACKGROUND: Active suppression by CD4(+)CD25(+) regulatory T lymphocytes plays an important role in the downregulation of T-cell responses to foreign and self-antigens.
OBJECTIVE: To analyze whether the CD4(+)CD25(+) regulatory T lymphocytes exist and function normally in malignant pleural effusion.
METHODS: The percentages of CD4(+)CD25(+) T lymphocytes in pleural effusion and peripheral blood from patients with lung cancer with malignant effusion, pleural lavage and peripheral blood from patients with lung cancer without effusion, and peripheral blood from healthy control subjects were determined by flow cytometry. The expressions of forkhead transcription factor Foxp3 and cytotoxic lymphocyte-associated antigen-4 were also examined. CD4(+)CD25(+) and CD4(+)CD25(-) T cells from pleural effusion and peripheral blood were isolated, and were cultured to observe the effects of CD4(+)CD25(+) cells on proliferation response of CD4(+)CD25(-) T cells in vitro. MAIN
RESULTS: There were increased numbers of CD4(+)CD25(+) T cells in malignant pleural effusion from patients with lung cancer compared with pleural lavage from patients with lung cancer without pleural effusion, and that these cells have constitutive high-level expression of Foxp3 and cytotoxic lymphocyte-associated antigen-4. Furthermore, CD4(+)CD25(+) T cells mediate potent inhibition of proliferation response of CD4(+)CD25(-) T cells, and anticytotoxic lymphocyte-associated antigen-4 monoclonal antibody could reduce the inhibitory activity of CD4(+)CD25(+) T cells.
CONCLUSIONS: The increased CD4(+)CD25(+) T cells found in malignant pleural effusion express high levels of Foxp3 transcription factor and potently suppress the proliferation of CD4(+)CD25(-) T cells, and cytotoxic lymphocyte-associated antigen-4 is involved in the suppressive activity of pleural CD4(+)CD25(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151041     DOI: 10.1164/rccm.200504-588OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

1.  Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion.

Authors:  Yakun Wen; Yong Wang; Zhenchuan Xing; Zongjian Liu; Ziliang Hou
Journal:  Cell Cycle       Date:  2018-12-27       Impact factor: 4.534

2.  Th17/Treg imbalance in malignant pleural effusion.

Authors:  Wei-Bing Yang; Zhi-Jian Ye; Fei Xiang; Jian-Chu Zhang; Qiong Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

3.  Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.

Authors:  Ricardo Mingarini Terra; Leila Antonangelo; Alessandro Wasum Mariani; Ricardo Lopes Moraes de Oliveira; Lisete Ribeiro Teixeira; Paulo Manuel Pego-Fernandes
Journal:  Lung       Date:  2016-06-14       Impact factor: 2.584

Review 4.  Malignant pleural effusion: tumor-host interactions unleashed.

Authors:  Georgios T Stathopoulos; Ioannis Kalomenidis
Journal:  Am J Respir Crit Care Med       Date:  2012-05-31       Impact factor: 21.405

5.  Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.

Authors:  Huseyin Yildirim; Muzaffer Metintas; Güntülü Ak; Sinan Erginel; Fusun Alatas; Emel Kurt; Selma Metintas; Irfan Ucgun
Journal:  Lung       Date:  2007-10-19       Impact factor: 2.584

6.  Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma.

Authors:  I Heier; P O Hofgaard; P Brandtzaeg; F L Jahnsen; M Karlsson
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

Review 7.  Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?

Authors:  Nicola Principe; Joel Kidman; Richard A Lake; Willem Joost Lesterhuis; Anna K Nowak; Alison M McDonnell; Jonathan Chee
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

8.  CD39+ regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism.

Authors:  Zhi-Jian Ye; Qiong Zhou; Jian-Chu Zhang; Xiao Li; Cong Wu; Shou-Ming Qin; Jian-Bao Xin; Huan-Zhong Shi
Journal:  Respir Res       Date:  2011-06-10

9.  Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer.

Authors:  Edin Jusufovic; Besim Prnjavorac; Ermina Iljazovic; Mitja Kosnik; Dragan Keser; Peter Korosec; Jugoslav Stahov; Edin Zukic; Rifat Sejdinovic; Ekrem Ajanovic
Journal:  Acta Inform Med       Date:  2011-09

Review 10.  Tumor-induced CD8+ T-cell dysfunction in lung cancer patients.

Authors:  Heriberto Prado-Garcia; Susana Romero-Garcia; Dolores Aguilar-Cazares; Manuel Meneses-Flores; Jose Sullivan Lopez-Gonzalez
Journal:  Clin Dev Immunol       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.